Sep 22, 2026 10 0
Uploaded by Genevieve
Favorite
Share
More Options
18
T cell receptor–engineered T cells targeting the TP53 R248Q neoantigen elicit antitumor effects in human cancer models_Page 1

Open in WPS to view all 18 pages